国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
8期
1481-1483
,共3页
白内障%超声乳化%角膜散光%Toric人工晶状体
白內障%超聲乳化%角膜散光%Toric人工晶狀體
백내장%초성유화%각막산광%Toric인공정상체
cataract%phacoemulsification%corneal astigmatism%Toric intraocular lens
目的：评价AcrySofToric人工晶状体(intraocularlens,IOL)植入矫正伴有规则性角膜散光白内障患者的临床效果及IOL的旋转稳定性。<br> 方法：随机选取南京医科大学第一附属医院眼科2012-06/2013-12的白内障合并规则角膜源性散光患者23例28眼行超声乳化白内障摘除联合AcrySofToricIOL植入术者,观察术后裸眼视力(UCVA),最佳矫正视力(BCVA),以及统计术前预期残余散光与术后实际残余散光,ToricIOL在囊袋内的旋转度。<br> 结果：术后3moUCVA为0.75±0.16,BCVA为0.84±0.15,BVCA与UCVA比较差异无统计学意义(t=1.036,P>0.05)。术前预期残余散光为0.28±0.12D,术后3mo实际残余散光为0.42±0.17D,预期散光值与实际残余散光值比较,差异无统计学差异(t=1.259,P>0.05)；ToricIOL术后1dIOL平均旋转3.02o±1.56o(0o~7o),术后3mo平均旋转3.28o±1.85o(0o~7o),其中25眼(89%)旋转<5o,3眼(11%)旋转5o~7o。<br> 结论：ToricIOL植入能够稳定并且有效地矫正白内障患者的角膜散光,并有较精准的散光矫正预测性。
目的：評價AcrySofToric人工晶狀體(intraocularlens,IOL)植入矯正伴有規則性角膜散光白內障患者的臨床效果及IOL的鏇轉穩定性。<br> 方法：隨機選取南京醫科大學第一附屬醫院眼科2012-06/2013-12的白內障閤併規則角膜源性散光患者23例28眼行超聲乳化白內障摘除聯閤AcrySofToricIOL植入術者,觀察術後裸眼視力(UCVA),最佳矯正視力(BCVA),以及統計術前預期殘餘散光與術後實際殘餘散光,ToricIOL在囊袋內的鏇轉度。<br> 結果：術後3moUCVA為0.75±0.16,BCVA為0.84±0.15,BVCA與UCVA比較差異無統計學意義(t=1.036,P>0.05)。術前預期殘餘散光為0.28±0.12D,術後3mo實際殘餘散光為0.42±0.17D,預期散光值與實際殘餘散光值比較,差異無統計學差異(t=1.259,P>0.05)；ToricIOL術後1dIOL平均鏇轉3.02o±1.56o(0o~7o),術後3mo平均鏇轉3.28o±1.85o(0o~7o),其中25眼(89%)鏇轉<5o,3眼(11%)鏇轉5o~7o。<br> 結論：ToricIOL植入能夠穩定併且有效地矯正白內障患者的角膜散光,併有較精準的散光矯正預測性。
목적：평개AcrySofToric인공정상체(intraocularlens,IOL)식입교정반유규칙성각막산광백내장환자적림상효과급IOL적선전은정성。<br> 방법：수궤선취남경의과대학제일부속의원안과2012-06/2013-12적백내장합병규칙각막원성산광환자23례28안행초성유화백내장적제연합AcrySofToricIOL식입술자,관찰술후라안시력(UCVA),최가교정시력(BCVA),이급통계술전예기잔여산광여술후실제잔여산광,ToricIOL재낭대내적선전도。<br> 결과：술후3moUCVA위0.75±0.16,BCVA위0.84±0.15,BVCA여UCVA비교차이무통계학의의(t=1.036,P>0.05)。술전예기잔여산광위0.28±0.12D,술후3mo실제잔여산광위0.42±0.17D,예기산광치여실제잔여산광치비교,차이무통계학차이(t=1.259,P>0.05)；ToricIOL술후1dIOL평균선전3.02o±1.56o(0o~7o),술후3mo평균선전3.28o±1.85o(0o~7o),기중25안(89%)선전<5o,3안(11%)선전5o~7o。<br> 결론：ToricIOL식입능구은정병차유효지교정백내장환자적각막산광,병유교정준적산광교정예측성。
AIM: To evaluate the clinical effect and the rotational stability of AcrySof Toric intraocular lens ( IOL ) implantation to correct preexisting corneal astigmatism in cataract surgery. <br> METHODS: Twenty-three patients ( 28 eyes ) were enrolled from the department of ophthalmology in the first Affiliated Hospital of Nanjing Medical University. All patients underwent similar phacoemulsification procedure combined with AcrySof Toric IOL implantation from June 2012 to December 2013. The uncorrected visual acuity ( UCVA ) , best corrected visual acuity ( BCVA ) , anticipated residual astigmatism, postoperative residual astigmatism, and Toric IOL axis were detected and measured. <br> RESULTS:Three months after operation, the UCVA of all eyes were 0. 75±0. 16 and the BCVA were 0. 84±0. 15, there was no significant difference between UCVA and BCVA ( t = 1. 036, P>0. 05 ). The anticipated residual astigmatism was ( 0. 28±0. 12 ) D. The actual residual astigmatism after 3mo of the operation was (0. 42±0. 17) D. There was no significant difference between anticipated and actual residual astigmatism (t=1. 259, P>0. 05). The mean axis rotation of Toric IOL was 3. 02o±1.56o (0o-7o) after 1d of operation and 3. 28o±1. 85o (0o-7o) after 3mo. Among all the eyes, 25 eyes ( 89%) rotated <5o, in 3 eyes (11%) rotated 5o-7o. <br> CONCLUSION: The AcrySof Toric IOL implantation shows good effectiveness, predictability and stability in correcting pre-existing astigmatism in cataract patients.
